Effect of hypoxic hypoxia and ritanserin on capillary flow and oxygenation in rabbit skeletal muscle

U. Gustafsson, F. Sjoberg, D. H. Lewis, Per Thorborg

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

This study examined capillary flow and oxygenation in rabbit skeletal muscle during hypoxic hypoxia (inspired oxygen fraction=0.10) and after administration of ritanserin (highly selective 5-hydroxytryptamine-2-receptor antagonist). Capillary flow (hydrogen clearance) or oxygen pressure was measured with a multiwire micro-electrode which was placed on the surface of the left vastus medialis muscle. For measurement of regional microcirculatory blood flow a laser-Doppler flowmeter probe was placed on the contralateral muscle. An experimental sequence with normoxaemia (arterial Po2 12.5 kPa), followed by hypoxaemia (arterial Po2 3.9 kPa) and thereafter sustained hypoxaemia (arterial Po2 4.0 kPa) during which ritanserin (0.035 mg kg-1 i.v.) was administered, was used. During hypoxaemia a decrease was seen in mean arterial pressure (MAP) by 27%, capillary flow by 25%, muscle oxygen pressure by 32% and laser-Doppler flowmetry (LDF) flow by 24%. After the administration of ritanserin the mean arterial pressure was further reduced by 7%, whereas the capillary flow increased by 59% and the muscle oxygen pressure by 31%. The LDF flow remained unchanged. These results demonstrate that, in this animal model, a decrease in skeletal muscle capillary flow and oxygenation during hypoxaemia can be reversed by the administration of ritanserin, despite a further reduction in blood pressure.

Original languageEnglish (US)
Pages (from-to)39-45
Number of pages7
JournalActa Physiologica Scandinavica
Volume150
Issue number1
StatePublished - 1994
Externally publishedYes

Fingerprint

Ritanserin
Skeletal Muscle
Rabbits
Oxygen
Muscles
Laser-Doppler Flowmetry
Pressure
Arterial Pressure
Flowmeters
Serotonin Receptors
Quadriceps Muscle
Regional Blood Flow
Hydrogen
Electrodes
Lasers
Animal Models
Hypoxia
Blood Pressure

Keywords

  • hydrogen clearance
  • laser-Doppler flowmetry (LDF)
  • micro-electrode
  • microcirculation
  • oxygen pressure
  • serotonin

ASJC Scopus subject areas

  • Physiology

Cite this

Effect of hypoxic hypoxia and ritanserin on capillary flow and oxygenation in rabbit skeletal muscle. / Gustafsson, U.; Sjoberg, F.; Lewis, D. H.; Thorborg, Per.

In: Acta Physiologica Scandinavica, Vol. 150, No. 1, 1994, p. 39-45.

Research output: Contribution to journalArticle

Gustafsson, U, Sjoberg, F, Lewis, DH & Thorborg, P 1994, 'Effect of hypoxic hypoxia and ritanserin on capillary flow and oxygenation in rabbit skeletal muscle', Acta Physiologica Scandinavica, vol. 150, no. 1, pp. 39-45.
Gustafsson, U. ; Sjoberg, F. ; Lewis, D. H. ; Thorborg, Per. / Effect of hypoxic hypoxia and ritanserin on capillary flow and oxygenation in rabbit skeletal muscle. In: Acta Physiologica Scandinavica. 1994 ; Vol. 150, No. 1. pp. 39-45.
@article{1734b5259e5c4467839aab03885e7d60,
title = "Effect of hypoxic hypoxia and ritanserin on capillary flow and oxygenation in rabbit skeletal muscle",
abstract = "This study examined capillary flow and oxygenation in rabbit skeletal muscle during hypoxic hypoxia (inspired oxygen fraction=0.10) and after administration of ritanserin (highly selective 5-hydroxytryptamine-2-receptor antagonist). Capillary flow (hydrogen clearance) or oxygen pressure was measured with a multiwire micro-electrode which was placed on the surface of the left vastus medialis muscle. For measurement of regional microcirculatory blood flow a laser-Doppler flowmeter probe was placed on the contralateral muscle. An experimental sequence with normoxaemia (arterial Po2 12.5 kPa), followed by hypoxaemia (arterial Po2 3.9 kPa) and thereafter sustained hypoxaemia (arterial Po2 4.0 kPa) during which ritanserin (0.035 mg kg-1 i.v.) was administered, was used. During hypoxaemia a decrease was seen in mean arterial pressure (MAP) by 27{\%}, capillary flow by 25{\%}, muscle oxygen pressure by 32{\%} and laser-Doppler flowmetry (LDF) flow by 24{\%}. After the administration of ritanserin the mean arterial pressure was further reduced by 7{\%}, whereas the capillary flow increased by 59{\%} and the muscle oxygen pressure by 31{\%}. The LDF flow remained unchanged. These results demonstrate that, in this animal model, a decrease in skeletal muscle capillary flow and oxygenation during hypoxaemia can be reversed by the administration of ritanserin, despite a further reduction in blood pressure.",
keywords = "hydrogen clearance, laser-Doppler flowmetry (LDF), micro-electrode, microcirculation, oxygen pressure, serotonin",
author = "U. Gustafsson and F. Sjoberg and Lewis, {D. H.} and Per Thorborg",
year = "1994",
language = "English (US)",
volume = "150",
pages = "39--45",
journal = "Skandinavisches Archiv F{\"u}r Physiologie",
issn = "0370-839X",
publisher = "John Wiley and Sons Ltd",
number = "1",

}

TY - JOUR

T1 - Effect of hypoxic hypoxia and ritanserin on capillary flow and oxygenation in rabbit skeletal muscle

AU - Gustafsson, U.

AU - Sjoberg, F.

AU - Lewis, D. H.

AU - Thorborg, Per

PY - 1994

Y1 - 1994

N2 - This study examined capillary flow and oxygenation in rabbit skeletal muscle during hypoxic hypoxia (inspired oxygen fraction=0.10) and after administration of ritanserin (highly selective 5-hydroxytryptamine-2-receptor antagonist). Capillary flow (hydrogen clearance) or oxygen pressure was measured with a multiwire micro-electrode which was placed on the surface of the left vastus medialis muscle. For measurement of regional microcirculatory blood flow a laser-Doppler flowmeter probe was placed on the contralateral muscle. An experimental sequence with normoxaemia (arterial Po2 12.5 kPa), followed by hypoxaemia (arterial Po2 3.9 kPa) and thereafter sustained hypoxaemia (arterial Po2 4.0 kPa) during which ritanserin (0.035 mg kg-1 i.v.) was administered, was used. During hypoxaemia a decrease was seen in mean arterial pressure (MAP) by 27%, capillary flow by 25%, muscle oxygen pressure by 32% and laser-Doppler flowmetry (LDF) flow by 24%. After the administration of ritanserin the mean arterial pressure was further reduced by 7%, whereas the capillary flow increased by 59% and the muscle oxygen pressure by 31%. The LDF flow remained unchanged. These results demonstrate that, in this animal model, a decrease in skeletal muscle capillary flow and oxygenation during hypoxaemia can be reversed by the administration of ritanserin, despite a further reduction in blood pressure.

AB - This study examined capillary flow and oxygenation in rabbit skeletal muscle during hypoxic hypoxia (inspired oxygen fraction=0.10) and after administration of ritanserin (highly selective 5-hydroxytryptamine-2-receptor antagonist). Capillary flow (hydrogen clearance) or oxygen pressure was measured with a multiwire micro-electrode which was placed on the surface of the left vastus medialis muscle. For measurement of regional microcirculatory blood flow a laser-Doppler flowmeter probe was placed on the contralateral muscle. An experimental sequence with normoxaemia (arterial Po2 12.5 kPa), followed by hypoxaemia (arterial Po2 3.9 kPa) and thereafter sustained hypoxaemia (arterial Po2 4.0 kPa) during which ritanserin (0.035 mg kg-1 i.v.) was administered, was used. During hypoxaemia a decrease was seen in mean arterial pressure (MAP) by 27%, capillary flow by 25%, muscle oxygen pressure by 32% and laser-Doppler flowmetry (LDF) flow by 24%. After the administration of ritanserin the mean arterial pressure was further reduced by 7%, whereas the capillary flow increased by 59% and the muscle oxygen pressure by 31%. The LDF flow remained unchanged. These results demonstrate that, in this animal model, a decrease in skeletal muscle capillary flow and oxygenation during hypoxaemia can be reversed by the administration of ritanserin, despite a further reduction in blood pressure.

KW - hydrogen clearance

KW - laser-Doppler flowmetry (LDF)

KW - micro-electrode

KW - microcirculation

KW - oxygen pressure

KW - serotonin

UR - http://www.scopus.com/inward/record.url?scp=0028303210&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028303210&partnerID=8YFLogxK

M3 - Article

C2 - 8135122

AN - SCOPUS:0028303210

VL - 150

SP - 39

EP - 45

JO - Skandinavisches Archiv Für Physiologie

JF - Skandinavisches Archiv Für Physiologie

SN - 0370-839X

IS - 1

ER -